19th Annual Meeting of the European-Society-for-Clinical-Virology, Lisbon, PORTUGAL, SEP 14-17, 2016International audienc
Background and Aim: Interferon-a (IFN-alpha) based therapy is the main treatment used to control hep...
markdownabstract__Abstract__ The innate immune system forms the so-called first line of defense a...
Chronicity of hepatitis B (CHB) infection is characterized by a weak immune response to the virus. E...
Molecular basis of virus replication, viral pathogenesis and antiviral strategie
Le polyomavirus BK (BKPyV) est un polyomavirus humains infectant plus de 90 % de la population et gé...
Having been used in hepatitis B therapy for more than 20 years, interferon-alpha (IFN-α) is st...
International audienceReactivation of BK polyomavirus (BKPyV) infection is frequently increasing in ...
19th Annual Meeting of the European-Society-for-Clinical-Virology -- SEP 14-17, 2016 -- Lisbon, PORT...
International audienceBackground: Currently approved antiviral monotherapies against chronic hepatit...
Tribec- (TRBV) as well as Kemerovo virus (KEMV) are sheep tick (Ixodes persulcatus and Ixodes ricinu...
In a randomized controlled trial of recombinant α-2a interferon for chronic hepatitis B, interferon ...
International audienceChronic hepatitis B virus (HBV) infection remains a major challenge for clinic...
ABSTRACTS OF 22ND MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION, GRAZ (AUSTRIA) APRIL ...
Item does not contain fulltextThe 31(st) International Conference on Antiviral Research (ICAR) was h...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background and Aim: Interferon-a (IFN-alpha) based therapy is the main treatment used to control hep...
markdownabstract__Abstract__ The innate immune system forms the so-called first line of defense a...
Chronicity of hepatitis B (CHB) infection is characterized by a weak immune response to the virus. E...
Molecular basis of virus replication, viral pathogenesis and antiviral strategie
Le polyomavirus BK (BKPyV) est un polyomavirus humains infectant plus de 90 % de la population et gé...
Having been used in hepatitis B therapy for more than 20 years, interferon-alpha (IFN-α) is st...
International audienceReactivation of BK polyomavirus (BKPyV) infection is frequently increasing in ...
19th Annual Meeting of the European-Society-for-Clinical-Virology -- SEP 14-17, 2016 -- Lisbon, PORT...
International audienceBackground: Currently approved antiviral monotherapies against chronic hepatit...
Tribec- (TRBV) as well as Kemerovo virus (KEMV) are sheep tick (Ixodes persulcatus and Ixodes ricinu...
In a randomized controlled trial of recombinant α-2a interferon for chronic hepatitis B, interferon ...
International audienceChronic hepatitis B virus (HBV) infection remains a major challenge for clinic...
ABSTRACTS OF 22ND MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION, GRAZ (AUSTRIA) APRIL ...
Item does not contain fulltextThe 31(st) International Conference on Antiviral Research (ICAR) was h...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background and Aim: Interferon-a (IFN-alpha) based therapy is the main treatment used to control hep...
markdownabstract__Abstract__ The innate immune system forms the so-called first line of defense a...
Chronicity of hepatitis B (CHB) infection is characterized by a weak immune response to the virus. E...
DOI
Add to ORKG